Alaunos Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$2
$4
Gross Profit
-185
2
4
EBITDA
-1,159
-1,038
-1,073
-742
EBIT
-1,159
-1,038
-741
-741
Net Income
-1,159
-1,051
-1,073
-742
Net Change In Cash
0
0
2
4
Free Cash Flow
-941
-701
-772
-592
Cash
1,938
2,879
319
1,091
Basic Shares
2,183
1,676
1,601
1,601

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$10
$5
$2,922
$398
Gross Profit
10
-4,798
2,922
398
EBITDA
-4,677
-30,904
-31,817
-74,965
EBIT
-4,679
-33,219
-34,576
-77,562
Net Income
-4,679
-35,140
-37,730
-78,751
Net Change In Cash
10
5
2,922
398
Cost of Revenue
-23,058
Free Cash Flow
-4,971
-30,339
-29,448
-64,791
Cash
1,091
6,062
39,058
76,054
Basic Shares
1,601
1,599
1,447
1,429

Earnings Calls

QuarterEPS
2025-09-30
-$0.55
2025-06-30
-$0.63
2025-03-31
-$0.67
2024-12-31
-$0.46